迪高替尼软膏国内能买到吗？在哪能买到？

Introduction: Digotinib ointment is a new type of external JAK inhibitor that has not yet been approved for marketing in mainland China. If patients want to purchase the drug, they need to obtain the original Japanese version through formal overseas channels. During use, special attention must be paid to administration site restrictions, infection management, and long-term monitoring to reduce potential risks.

Is Digotinib Ointment available in China?

The drug market in mainland China has not yet been officially approved, which has caused some trouble to patients who need this drug treatment.

Domestic Approval Status

As of May 2025, China’s National Medical Products Administration has not yet approved digotinib ointment for marketing, and domestic medical institutions and regular pharmacies are unable to provide the drug.

Alternative drug selection

At present, other similar external preparations of JAK inhibitors have been approved in China, and patients can choose alternative treatment options that are already on the market under the guidance of a doctor.

It is recommended to pay attention to the official website of the State Food and Drug Administration for the latest approval progress, and do not purchase through informal channels before the drug is officially approved.

Where to buy Digotinib Ointment

Although it is not available for purchase domestically, patients can still obtain genuine Digotinib Ointment through specific overseas channels.

Regular medical institutions in Japan

Japan is the main market country for this drug. Patients can purchase the original drug at the dermatology department of local hospitals or designated pharmacies with a valid prescription.

Cross-border medical services

Some professional cross-border medical platforms provide purchase services and can assist patients to purchase from regular Japanese pharmacies and handle international transportation.

When purchasing, be sure to verify the supplier’s qualifications and provide the original packaging, instructions and formal purchase certificate of the drug.

Precautions for the use of Digotinib Ointment

The correct use of Digotinib Ointment is crucial to reducing the risk of adverse reactions.

Administration site restrictions

Avoid applying ointment to special parts such as mucous membranes and ulcers. If it accidentally gets into your eyes, rinse immediately with plenty of water and seek medical advice.

Infection management

When combined with skin infection, the infection should be controlled first, and if necessary, the infected area should be isolated before medication. Observe the application site closely for reactions.

Long-term monitoring requirements

Regularly evaluate the treatment effect and pay attention to possible delayed reactions such as folliculitis. If any abnormality occurs, you should seek medical advice promptly and adjust the plan.

Although Digotinib ointment is a topical drug, it still needs to be used with caution in special groups. Children, pregnant women and people with damaged skin barriers should consult a professional physician before use to avoid adverse reactions or weakened efficacy due to ignoring precautions. If serious adverse reactions occur during use, the drug should be discontinued immediately and professional medical personnel should be consulted for treatment options.